Clinical trial phase III, randomized, double-blind, prospective, comparative non-inferiority to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC stimulation of appetite in children, adults and elderly. A total of 150 patients, distributed as follows:~25 patients treated children Apetiviton BC,25 patients treated children Petivit BC, (2-6 years).~25 adult patients treated with Apetiviton BC,25 adult patients treated with Petivit BC, (18-50 years.~25 elderly patients treated with Apetiviton BC,25 elderly patients treated with Petivit BC. (60-80 years.
Clinical study phase III, randomized, double-blind, prospective, comparative non-inferiority to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC in appetite stimulate in children, adults and elderly.